Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
236.99
+12.11 (5.39%)
Last updated: Mar 28, 2025
SHA:688506 Revenue
In the year 2024, Sichuan Biokin Pharmaceutical had annual revenue of 5.82B CNY with 936.31% growth. Sichuan Biokin Pharmaceutical had revenue of 160.16M in the quarter ending December 31, 2024, a decrease of -13.04%.
Revenue
5.82B
Revenue Growth
+936.31%
P/S Ratio
17.00
Revenue / Employee
2.79M
Employees
2,086
Market Cap
99.04B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.82B | 5.26B | 936.31% |
Dec 31, 2023 | 561.87M | -141.41M | -20.11% |
Dec 31, 2022 | 703.28M | -93.45M | -11.73% |
Dec 31, 2021 | 796.73M | -215.98M | -21.33% |
Dec 31, 2020 | 1.01B | -193.91M | -16.07% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |